戻る Agenda
How Can the EU Regulatory Network Support Innovation?
Session Chair(s)
Esa Henrik Heinonen, DrMed
Director, Assessment of Medicinal Products
Finnish Medicines Agency (Fimea), Finland
The session will review the support mechanism of the medicines regulators and HTA bodies for the innovators to enhance innovation. It also will review the new Horizon 2020 STARS program aiming to improve the regulatory knowledge of academic groups.
Speaker(s)
EMA’s Perspective
Tony Humphreys, MPHARM
European Medicines Agency, Netherlands
Head of the Regulatory Science and Innovation Task Force
What is The EU-Innovation Network?
Esa Henrik Heinonen, DrMed
Finnish Medicines Agency (Fimea), Finland
Director, Assessment of Medicinal Products
STARS Project – Approaching Academic Centers
Julia Stingl, DrMed
Bfarm, Germany
Vice President and Head of Research
IMI Projects – Role of a Regulator
Isabelle Bekeredjian-Ding, MD
Paul-Ehrlich-Institut (PEI), Germany
Head of Division of Microbiology
EU Cooperation on HTA - Today and Tomorrow
Anna-Eva Ampelas, LLM
European Commission, Belgium
Head of Unit, Unit B6 Medical Devices and Health Technology Assessment, DG SANTE